Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Addex Pharmaceuticals completes CHF50.5mm Series B round

Executive Summary

Addex Pharmaceuticals (developing therapeutics to treat central nervous system disorders) raised CHF50.5mm ($39mm) in a Series B financing led by returning shareholder Techno Venture Management. Other returning backers Index Ventures and Sofinnova Partners were joined by new investors PolyTechnos Venture-Partners, BioOne Capital (investment arm of the Singapore Economic Development Board), Vinci Capital & Renaissance, Initiative Capital (managed by Defi Gestion SA), and Fulcrum Pharma Development.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies